Back to Portfolio

Lunaphore

Tumor analysis and classification platform
 


Lunaphore has developed a next-generation tissue diagnostics platform for the analysis and classification of tumors and other solid tissues. Based on a proprietary microfluidic chip technology and a bench top device, the platform offers customers unprecedented speed, accuracy and flexibility.

Lunaphore’s unique solution meets today’s needs, where medicine is becoming more personalized and whole panels of biomarkers play an increasing role.

 

Homepage Facebook Twitter Linkedin 

 

Lunaphore in the News:

Redalpine leads Series A round for revolutionary tissue diagnostics company Lunaphore - See more at: http://redalpine.com/blog/redalpine-news/#sthash.XZ1rLxaO.dpuf

Lunaphore and Perkin Elmer announce collaboration

Lunaphore closes CHF 6m financing round

Four Redalpine companies among the Top 30 Swiss start-ups

Lunaphore's best pitch

Three Redalpine companies among the Top 10 Swiss start-ups

Knip, Trekksoft and Lunaphore among top 10 Swiss start-ups

Redalpine leads Series A round for revolutionary tissue diagnostics company Lunaphore

 

Jobs at Lunaphore